Month: November 2020

The same week that a yet-to-be peer-reviewed paper found that people infected with Covid-19 may have immunity that last years or longer, the CDC released another study that said that may not be the case.  The CDC study, published in the Nov. 27 issue of the agency’s Morbidity and Mortality Weekly Report (MMWR), found that,
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 24 2020 In the most comprehensive analysis to date of U.S. children tested and treated for COVID-19, an organization representing seven of the nation’s largest pediatric medical centers reports that some groups of children are faring significantly worse than children in general during the pandemic. Findings from the PEDSnet organization–which
0 Comments
The following is an excerpt from a new book, Patients at Risk: The Rise of the Nurse Practitioner and Physician Assistant in Healthcare, by Rebekah Bernard, MD. What is the difference between the practice of medicine and the practice of advanced nursing? Advocates say that nurse practitioners are capable of autonomously diagnosing and treating acute
0 Comments
Older adults should be recommended for hospital-based lifestyle interventions to reduce weight, say UK investigators after finding there was no difference in weight loss between older and younger individuals in their program for those with morbid obesity. Thomas M. Barber, PhD, and colleagues looked back at nearly 250 randomly selected adults who attended their obesity
0 Comments
An eye exam may be all that is needed to diagnose Parkinson’s disease, new research shows. Using an advanced machine-learning algorithm and fundus eye images, which depict the small blood vessels and more at the back of the eye, investigators are able to classify patients with Parkinson’s disease compared against a control group. “We discovered
0 Comments
The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). Calculation was based on the analysis of data on volunteers (n = 18,794) who received both the first and second doses of the Sputnik
0 Comments
FDA Approves Danyelza (naxitamab-gqgk) for the Treatment of Neuroblastoma NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the U.S. Food and Drug Administration
0 Comments
Decreases in hospital attendances and admissions amid fears of COVID-19 may result in avoidable harm for under 16s say researchers, who warn against the “unintended consequences of pandemic control measures”. Research led by Dr Rachel Isba from Lancaster University, Dr Rachel Jenner from Royal Manchester Children’s Hospital, and Dr Marc Auerbach from Yale University analyzed
0 Comments
I stared at the black, ulcerated foot before me and two thoughts ran through my mind: undocumented immigrant and minimal healthcare access. “Why did you not come to the clinic earlier? You have diabetes, it’s dangerous to let this kind of wound fester.” Diabetes doesn’t play nice with foot wounds, and those that go untreated
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. For Christina Nester, the pandemic lull in Massachusetts lasted about three months through summer into early fall. In late June, St. Vincent Hospital had resumed elective surgeries, and the unit the 48-year-old nurse works on switched back from taking care of
0 Comments
If an apple a day can keep the doctor away — well, imagine what a kiwi can do. Kiwifruit do not get the attention they deserve. These sweet, furry little fruits are a nutrient-dense fruit with many health benefits.  One raw green kiwifruit has about 61 calories, 15 grams total carbohydrates, 3 grams of fiber
0 Comments
Financial payments from the pharmaceutical industry to US physicians were associated with increased prescribing of the paying manufacturer’s drug, concludes a review of 36 recent studies. It also found evidence of “a temporal association and dose-response [that] suggest a causal relationship.” The review was published November 24 in the Annals of Internal Medicine. “The large
0 Comments
FDA Approves Imcivree (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency BOSTON, Nov. 27, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, announced today that the U.S. Food &
0 Comments
A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. Dado Ruvic | Reuters More data will be needed from AstraZeneca‘s coronavirus vaccine trials to determine the drug’s safety and efficacy following concerns from experts in the U.S., scientists from the University of Oxford and the
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 24 2020 A new paper from the Department of Psychiatry and the Population Health program at University Hospitals (UH) Cleveland Medical Center, proposes a framework for eliminating defects in behavioral health treatment. Entitled “Eliminating Defects in Behavioral Health Treatment,” the paper was published online on Nov. 19 in the journal
0 Comments
The COVID-19 pandemic has affected almost everyone, whether directly, through the loss of loved ones, or the impact on job security. Business has slowed down in many sectors and has been put to a standstill. It became clear that things we thought were imperative to our lives and functionality as human beings were “non-essential,” and
0 Comments
With most Americans in favor of legalized marijuana — and a growing number of states making the drug legal — how long before recreational pot becomes available across the US? Making marijuana legal has been a grassroots effort. Support has come from the ground up, and the laws have generally changed, not in the state
0 Comments
Three specific symptoms may help clinicians identify patients with borderline personality disorders (BPD) at highest risk for suicide. Results of a large longitudinal study show patients with BPD are at considerably higher risk of suicide attempts compared to patients with other personality disorders including schizotypal, avoidant, and obsessive compulsive personality disorder (OCPD). Furthermore, among DSM-5
0 Comments
Getting caught without a pad or a tampon outside the home is par for the course for lots of women. Ducking into a pharmacy or other store to get what’s needed is also run of the mill for them. But for women without financial resources, access to sanitary products isn’t always possible. At Target, for
0 Comments
When an 86-year-old male patient presented to Nishi Chandrasekaran, MBBS, at the Smell and Taste Treatment and Research Foundation in Chicago, Illinois, he initially complained of impaired memory and concentration as well as some olfactory and gait problems “Initially that was it. So we talked about these issues together and I suggested a few treatments, but
0 Comments
November 25, 2020 — Under FDA law, approval of a new drug requires substantial evidence of effectiveness and a demonstration of safety for the drug’s intended use(s).  The approval of remdesivir (Veklury) for the treatment of patients hospitalized with COVID-19 met this legal and scientific standard. BackgroundRandomized, controlled trials are the gold standard for evaluating
0 Comments
ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Vimpat (lacosamide) CV as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older and Vimpat injection for intravenous use in children four
0 Comments
Arcturus Therapeutics is co-developing a vaccine candidate for Covid-19 in collaboration with Duke-NUS Medical School in Singapore, called ARCT-021. Jakub Porzycki | NurPhoto | Getty Images SINGAPORE — A Covid-19 vaccine candidate co-developed by Singapore scientists has shown positive interim results and could be available as early as 2021. That’s according to American biopharmaceutical firm
0 Comments